News & Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Microbiology-Immunology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
- 09.11.2023
Northwestern Medicine scientists have developed an engineered probiotic capable of detecting inflammatory bowel disease, according to a study published in the Proceedings of the National Academy of Sciences.
- 08.17.2023
Northwestern Medicine scientists have discovered how HIV hijacks intracellular processes to proliferate and contribute to neurodegeneration, according to a new study published in Nature Communications.
- 06.06.2023
Northwestern Medicine investigators have developed a novel nanoparticle treatment for glioblastoma, according to a study published in Nature Communications.
- 04.06.2023
Alan Hauser, MD, PhD, vice chair of Microbiology-Immunology, has been named the new director of Feinberg’s Medical Scientist Training Program (MSTP), effective April 15.
- 02.21.2023
Feinberg scientists continue to investigate the lasting impact of the COVID-19 pandemic, from utilizing sentinel surveillance to monitor SARS-CoV-2 transmission rates to developing new approaches to monoclonal antibody therapy.
- 01.18.2023
Targeting cellular post-transcription mechanisms in the CD73 ectoenzyme may promote anti-tumor immunity and slow cancer progression in triple-negative breast cancer, according to a recent Northwestern Medicine study.
- 01.04.2023
Increased levels of the antibody immunoglobulin A (IgA) are correlated with the manifestation of several diseases and African ancestry, according to findings published in Nature Communications.
- 12.16.2022
Northwestern Medicine scientists have identified a new therapeutic target against tumor cells and developed a compound which slows tumor growth and bolsters immune response.
- 12.01.2022
The presence of food-specific IgA antibodies in the gut does not prevent peanut or egg allergies from developing in children, according to a Northwestern Medicine-led study published in Science Translational Medicine.
- 10.13.2022
Targeting internal proteins instead of spike proteins may be a promising strategy for monoclonal antibody therapy to combat SARS-CoV-2, the virus that causes COVID-19.
- 10.05.2022
Northwestern Medicine investigators have uncovered novel regulatory mechanisms that promote bacterial survival, according to findings published in PNAS.